As the coronavirus pandemic rages on amid a severe economic crisis, the cannabis industry remains relatively strong. The controversial plant has grown immensely popular over the past few years, especially after researchers started looking into its purported medical abilities. Users say cannabis can be effective against a variety of ailments ranging from chronic pain and anxiety to fighting cancer and regulating and preventing diabetes, but only a few of these claims are backed by hard data. At the moment, it is nearly impossible for American researchers to study cannabis as it is still classified as a Schedule 1 substance.
Canada, on the other hand, has legalized both medical and recreational cannabis and researchers are free to study the effect of cannabis on human illness. In a bid to collect more hard data on cannabis, the University Health Network (“UHN”) in Canada is embarking on a six-month study to see whether there is any truth behind the claims that cannabis can help patients. Dubbed ‘The Medical Cannabis Real World Evidence Study,’ it is looking to enroll at least 2,000 people who…
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]
CNW420 is part of the InvestorBrandNetwork.